Pittsburgh-based CytoAgents with Covid innovation starts clinical trials,

“We’ve been able to expedite a smaller trial, which is why it will end so quickly and we can go right into Phase 2.” …, “We’ve been able to expedite a smaller trial, which is why it will end so quickly and we can go right into Phase 2.” …, Read More